ClinConnect ClinConnect Logo
Search / Trial NCT03105687

Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake

Launched by COMENIUS UNIVERSITY · Apr 3, 2017

Trial Information

Current as of May 09, 2025

Completed

Keywords

M Health Sms Reminders Adherence Antihypertensive Drugs Pharmacists Cost Effectiveness

ClinConnect Summary

Hypertension belongs to the main risk factors of cardiovascular diseases, which are the leading cause of morbidity and mortality in the world and in the Slovak Republic. Despite the availability of effective antihypertensive treatment, blood pressure control remains a serious problem. Poor adherence to blood pressure-lowering medication is considered to be the key factor for uncontrolled blood pressure. Studies estimate the overall adherence to medication in patients with chronic diseases at around 50%. Slovak studies report even significantly lower adherence rates (15-19%), which underline...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 55 years (from the day of the 55. birthday inclusive)
  • Diagnosis of primary (essential) hypertension (I10 according to International Classification of Diseases (ICD-10))
  • Filling of blood pressure-lowering prescription(s) at trial recruitment (Visit 1)
  • Duration of antihypertensive drug treatment for at least 1 year without any discontinuation
  • Ownership of a mobile phone for personal use with the ability to open and read SMS
  • Understanding of Slovak language on native-speaker level
  • Informed consent for participation in the clinical trial and personally signed Informed Consent Form
  • Exclusion Criteria:
  • Exclusion criteria assessed prior to patient enrolment (by trial pharmacists):
  • Planned hospitalisation during the trial period (3 months)
  • Biological impairment affecting the ability to read the SMS (e.g. loss of vision, visual field cuts, aphasia)
  • Living in the same household with another trial participant
  • Participation in another clinical trial
  • Exclusion criteria assessed after patient enrolment (by trial pharmacists and project leader):
  • Hospitalisation during the trial period
  • Patient informs he/she won't be able to participate in the trial
  • Withdrawal of Informed Consent

About Comenius University

Comenius University, established in 1919 and located in Bratislava, Slovakia, is a leading academic institution renowned for its commitment to research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive expertise in health sciences and collaborative networks to advance medical research, improve patient outcomes, and foster innovation in clinical practices. By promoting rigorous scientific methodologies and ethical standards, Comenius University aims to contribute significantly to the global body of medical knowledge while enhancing the quality of healthcare delivery.

Locations

Banská Bystrica, , Slovakia

Banská Bystrica, , Slovakia

Bratislava, , Slovakia

Bratislava, , Slovakia

Bratislava, , Slovakia

Dubnica Nad Váhom, , Slovakia

Dubnica Nad Váhom, , Slovakia

Galanta, , Slovakia

Hnúšťa, , Slovakia

Kežmarok, , Slovakia

Liptovský Mikuláš, , Slovakia

Malacky, , Slovakia

Martin, , Slovakia

Martin, , Slovakia

Piešťany, , Slovakia

Prešov, , Slovakia

Rimavská Sobota, , Slovakia

Rožňava, , Slovakia

Spišská Nová Ves, , Slovakia

Trenčín, , Slovakia

Trenčín, , Slovakia

Vranov Nad Topľou, , Slovakia

Zvolen, , Slovakia

žilina, , Slovakia

Patients applied

0 patients applied

Trial Officials

Zuzana Haramiova, PharmDr.

Study Director

Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

Magdalena Kuzelova, Prof., PharmDr., PhD.

Study Chair

Faculty of Pharmacy Comenius University in Bratislava, Department of Pharmacology and Toxicology

Donald M. Morisky, Sc.D., M.S.P.H., Sc.M.

Study Chair

Fielding School of Public Health, Department of Community Health Sciences

Tomas Tesar, Doc., PharmDr., PhD, MBA

Study Chair

Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

Michal Stasko, PharmDr.

Study Chair

Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

Martin Hulin, Ing., Mgr., PhD.

Study Chair

Research Institute for Child Psychology and Pathopsychology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials